News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2019 Shelley Wood December 31, 2019
News Daily News NOBLE at 5 Years: New Data Favor CABG for Left Main Disease Todd Neale December 23, 2019
News Daily News FDA Approves Icosapent Ethyl for Reducing CVD Events Michael O'Riordan December 13, 2019
News Daily News CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials Caitlin E. Cox December 11, 2019
News Daily News Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk Michael O'Riordan December 03, 2019
News Conference News AHA 2019 Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE Yael L. Maxwell November 21, 2019
News Conference News AHA 2019 Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial Shelley Wood November 18, 2019
News Conference News AHA 2019 Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT Yael L. Maxwell November 17, 2019
News Conference News AHA 2019 ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD Todd Neale November 16, 2019
News Conference News AHA 2019 COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine Caitlin E. Cox November 16, 2019
News Daily News Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms Todd Neale November 07, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News Dramatic Swings in Household Income Linked to CVD Risk: ARIC Michael O'Riordan October 09, 2019
News Conference News TCT 2019 TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients Todd Neale October 03, 2019
News Daily News TCT 2019 BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On L.A. McKeown October 02, 2019
News Conference News TCT 2019 GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients? Todd Neale September 30, 2019
News Opinion Off Script TCT 2019 Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall Kwan S. Lee September 29, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019